The effect of prednisolone initiation and short-term discontinuation on the clinical assessment of polymyalgia rheumatica
This study shows that clinically assessing PMR becomes challenging after prednisolone initiation, and that short-term prednisolone discontinuation does not improve clinical assessment to pre-treatment levels. Consequently, the study supports recommendations of deferring prednisolone initiation until after specialist evaluation in individuals suspected of having PMR.
Authors
- Ellen‐Margrethe Hauge (ORCID: https://orcid.org/0000-0003-2562-9174)
- René Østgård (ORCID: https://orcid.org/0000-0001-6124-8972)
- Susanne K. Kjær (ORCID: https://orcid.org/0000-0002-8347-1398)
- Christoffer Våben (ORCID: https://orcid.org/0000-0003-2704-4081)
- Kresten Krarup Keller (ORCID: https://orcid.org/0000-0003-2474-3389)
- Line Thorndal Moll (ORCID: https://orcid.org/0000-0003-4132-0310)
- Jesper Blegvad‐Nissen
- Berit Dalsgaard Nielsen (ORCID: https://orcid.org/0000-0001-6291-157X)
- Christoffer Mørk
- A. Nielsen (ORCID: https://orcid.org/0000-0001-8180-6871)
- Tue Kruse Rasmussen (ORCID: https://orcid.org/0000-0003-0132-4026)
- Christian Møller Sørensen
- Emil Barner Dalgaard
- Marc K Nielsen
- Ib Tønder Hansen (ORCID: https://orcid.org/0009-0007-5610-1707)
Institutions
- Aarhus University (DK)
- Glostrup Hospital (DK)
- Aarhus University Hospital (DK)
- Hôpital régional (CH)
- Regionshospitalet Silkeborg (DK)
- Regional Hospital Horsens (DK)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1093/rheumatology/keaf170
- Citations
- 3
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 4.88